Fecha de actualización: Septiembre de 2018

 

Discovery
Click for more info Project Teaser


 Indication
 Target
CM-352 Bleeding
Disorders
Research Group		 MMP10 & MMP3

 
CM-272 Cancer
AML & HCC
Research Group		 DNMT & G9a

 
CM-414 Alzheimer’s Disease
Research Group		 PDE5 & HDACs

 
CM-1315 Onco-immunology

Research Group

 Disruption of FOXP3 dimerization

 
Apo-Insulin

Diabetes

Research Group

 Insulin
Receptor

 
Sushi-IL15-
Apo		 Onco-immunology
Research Group		 Receptor
IL-15

 
CM-1349 Acute
intermittent porphyria
Research Group		 PBGD

 
CIRP-vaccine Onco-immunology
Research Group		 CD8 T cell simulation

 
Eliratra Onco-immunology

Research Group

 Immune response

 
Apo-
FGF19		 Liver
regeneration
Research Group		 FGF19 receptor

 
Target ID In vitro
Assays		 Hit ID In vivo PoC
/ Lead id 		ADMET / PK
Optimización 		Preclinical Clinical
 
   
   
   
     
     
     
     
     
     
IP
ok
ok
ok
ok
ok
ok
ok
ok
ok
ok
 


 

Early Discovery
Click for more info Project Teaser


 Indication
 Target
CM-166 Heart Failure fibrosis

Research Group

 Novel Target (undisclosed)

 
Viro Therapy Onco-immunology
Research Group

Inmune response

 
CM-1351 Onco-immunologyResearch Group

 Disruption Foxp3/ NFAT interaction

 
GPCR-X antagonist Alzheimers's Disease
Research Group		 Novel Target (GPCR-undisclosed)

 
CM-3132 Dravet Syndrome
Research Group		 SCN1A

 
Target ID In vitro
Assays		 Hit ID In vivo PoC
/ Lead id 		ADMET / PK
Optimización 		Preclinical Clinical
   
   
     
     
     
Partners
 IP
Undisclosed in-process
   
Undisclosed in-process
ok in-process
  in-process
 


 

Licensed Products in PreClinical & Clinical Phases
Click for more info Project Teaser


 Indication
CardioPatch Heart Failure

Research Group
EDA vaccine Cervical
Cancer

Research Group
a5-IFN Manufacturing
rh-CT 1 * Acute kidney injure
AAV-PBGD * Acute intermittent Porphyria
CM-144 * Scleroderma

 
R&D Preclinical
Phase I Phase II Phase III
     
     
 
 
 
 
Licensed
 IP
Viscofan ok
Formune ok
BioTechpharma ok
Digna Biotech ok
Uniqure ok
Digna Biotech ok

 

* Terminated


 

Diagnostics

Click for more info Project Teaser


Indication
C4 activation fragment Lung Cancer

Research Group
BM Panel Heart Failure

Research Group
ADC Pronostic Index Lung adenocarcinoma

Research Group
SCC Pronostic Index Lung squamous cells carcinoma

Research Group
Biomarker
identification		 Analytical
Validation
Retrospective Clinical
Validation		 Protrospective Clinical
Validation		 Regulation
Process		 Clinical
Utility
   
   
       
       
Partners
 Licensed
 IP
ok   ok
     
    ok
    ok